The maintenance of an Outperform rating suggests that the analyst continues to have a positive view on CVS Health's future performance. However, the reduction in the price target could imply a more conservative view on the growth prospects or valuation of the company. This news is likely to be seen as mildly negative by investors, as it suggests a slight decrease in expected future stock performance. However, since the rating remains positive, the overall impact on the stock price may be neutral in the short term.